Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI PET/CT or PET/MR in Malignant Tumors
NCT06270394Completed
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Apr 2022
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: 68Ga-Fibroblast Activation Protein Inhibitor-04 Uptake in Gastrointestinal Cancer: Comparison with 18F-FDG at 38 months. Started Apr 2022; status: completed.
Beyond the preview
Go deeper on NCT06270394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06270394.